Delivery Order SPE2DB22D2006-SPE2DB25FW3LT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a $1,434.58 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50 units. This competitively awarded, firm fixed-price contract is set to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger vehicle, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,618.80 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 milliliters. This contract represents a competitively awarded, non-set-aside delivery order with firm fixed pricing under an Indefinite Delivery Contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15,...
- This delivery order, valued at $3,055.46, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50 milliliters) to support federal medical procurement needs. The contract employs firm fixed pricing and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's military and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,980.44 firm fixed-price delivery order is for 4,565,422,154 units of the antibiotic drug Meropenem-0.9% Sodium Chloride 1 gram/50s. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,940.78 firm fixed-price delivery order is for the supply of Meropenem 2 gram vials, a critical antibiotic medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,746.66, is for the supply of 4567008715 - Meropenem-0.9% Sodium Chloride 1 Gram/50s. The contract is a firm fixed-price award with an ultimate completion date of January 23, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Meropenem-0.9% Sodium Chloride 1 gram/50s, a type of antibiotic medication. The contract has a firm fixed price of $1,464.38 and a completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $1,912.91, is for the delivery of MEROPENEM-0.9% NACL 1 GRAM/50S, a medication, to support military healthcare programs. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of March 31, 2025. It is not designated as a set-aside contract....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,038.13, is for the delivery of Meropenem-0.9% Sodium Chloride 1 Gram/50s, a type of injectable medication. The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3LTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this delivery order and represents a child contract under the company's broader federal pharmaceutical supply agreements. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its critical role in supplying specialty medications, generic drugs, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor competing in open competition, AmerisourceBergen maintains the capability to fulfill diverse medical procurement requirements across multiple therapeutic domains supporting the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/14/25 |